ROCHESTER — This fall, new research on lung cancer survival, diagnosis and screening have made headlines. Lung cancer is the most common cause of cancer deaths in the U.S. and worldwide. "But I think ...

Postop RT: Meaningful Survival Improvement in N2 Lung Cancer Dr Mark Kris discusses the use of postoperative radiation therapy in patients with N2 disease. Medscape Oncology, February 23, 2023 Disease ...

While a decade ago the prognosis of lung cancer patients was very disappointing, nowadays a substantial evolution is driven by targeted treatments and immuno-oncology. With extended, scaled genetic ...

More than 150 lung cancer researchers, clinicians and patient advocates from around the country gathered at Fred Hutch last ...

DUBLIN--(BUSINESS WIRE)--The "Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive ...

Dr Narjust Florez explores the transformative shifts in the treatment landscape for early-stage non–small cell lung cancer over the years, particularly emphasizing the significant changes observed ...

SAN FRANCISCO--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape ...

As professionals from across the oncology landscape gather at the 2026 American Society of Clinical Oncology (ASCO) congress in Chicago, many are looking to key readouts in lung cancer, the leading ...

Retrospective Analysis of BRCA-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase Inhibitors The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of ...

People with advanced lung cancer represent a distinct group whose needs remain understudied, especially compared with people diagnosed with limited-stage disease. Fortunately, novel treatments such as ...